Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link

Disclaimer: Early release articles are not considered as final versions. Any changes will be reflected in the online version in the month the article is officially released.

Volume 31, Number 9—September 2025

CME ACTIVITY - Research

Rickettsioses as Underrecognized Cause of Hospitalization for Febrile Illness, Uganda

Paul W. BlairComments to Author , Sultanah Alharthi, Andrés F. Londoño, Abdullah Wailagala, Yukari C. Manabe, J. Stephen Dumler, and the Acute Febrile Illness and Sepsis in Uganda Study Teams1
Author affiliation: Vanderbilt University Medical Center, Nashville, Tennessee, USA (P.W. Blair, S. Alharthi); Uniformed Services University, Bethesda, Maryland, USA (A.F. Londoño, J.S. Dumler); Makerere University, Kampala, Uganda (A. Wailagala); Johns Hopkins University School of Medicine, Baltimore, Maryland, USA (Y.C. Manabe)

Main Article

Table 3

Clinical examination and laboratory features among diagnostic classes in a study of rickettsioses as an underrecognized cause of hospitalization for febrile illness, Uganda *

Characteristic Total, n = 329 Malarial, n = 59 Rickettsial, n = 33 p value, rickettsial vs. malarial† Nonmalarial, n = 237 p value, rickettsial vs. nonmalarial†
Rash on examination, no. (%)‡ 21/328 (6.4) 2/59 (3.4) 2/33 (6.1) 0.616 17/236 (7.2) >0.999
Leukocytes, × 103 cells/µL§ 5.5 (3.9–8.4) 4.7 (3.3–6.6) 6.2 (4.6–8.1) 0.012 5.6 (4.1–9.4) 0.900
Platelet count, × 103 cells/µL ¶ 205.0 (134.7–289.0) 104.1 (64.2–179.0) 168.0 (116.9–264.5) 0.007 227.0 (171.0–311.0) 0.013
AST, U/L ‡# 35.0 (26.0–59.0) 32.0 (24.0–42.0) 38.0 (26.0–92.0) 0.081 36.0 (26.0–61.0) 0.524
ALT, U/L 23.0 (18.0–36.0) 21.0 (17.0–28.0) 25.0 (19.0–44.0) 0.119 24.0 (18.0–37.0) 0.596
Creatinine, mg/dL** 0.8 (0.5–1.0) 0.8 (0.0–1.0) 0.8 (0.0–1.1) 0.204 0.8 (0.6–1.0) 0.541

*Values are median (interquartile range) except as indicated. ALT, alanine transaminase; AST, aspartate transaminase; qSOFA, quick sepsis organ failure assessment. †Fisher exact test, Wilcoxon rank-sum test, or Pearson χ2 test. ‡No. positive/no. tested (%). Missing for 1 of 329 participants. §Missing for 18 of 328 participants. ¶Missing for 19 of 328 participants. #Missing for 1 of 329 participants. **Missing for 2 of 322 participants.

Main Article

1Members are listed at the end of this article.

Page created: July 09, 2025
Page updated: August 22, 2025
Page reviewed: August 22, 2025
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external